Semaglutide is a GLP-1 receptor agonist while tirzepatide activates both GIP and GLP-1 receptors, which can lead to larger average weight loss in some trials
Met, with its antioxidant and anti-apoptotic properties, protects the reproductive system and improves sperm count and mobility in diabetic patients with infertility while increasing testosterone hormone levels in blood serum and testicles []
Eight nursing mothers, who were using subcutaneous semaglutide in doses ranging from 0.25 to 1 mg weekly, donated milk samples at 0,12 and 24 hours after a dose
These changes were also associated with an improvement in exercise performance
[DOI] [PubMed] [Google Scholar] 23.Marso S
One of the biggest factors is insulin resistance, a key symptom of PCOS